Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23714399 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients
Condition: Liver Transplantation
Interventions: Drug: Tacrolimus (reduced tacrolimus);   Drug: Tacrolimus (tacrolimus elimination);   Drug: Tacrolimus (tacrolimus control);   Drug: Everolimus (reduced tacrolimus);   Drug: Everolimus (tacrolimus elimination);   Drug: Corticosteroids

Indicates status has not been verified in more than two years